Metraipolis › archive › dc_7ae93d60ceab
Glucocorticoid reduction after starting crinecerfont in pediatric patients with classic congenital adrenal hyperplasia: practical perspectives — Europe PMC PMID:42082437
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42082437
- DOI
- 10.1210/clinem/dgag192
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T13:57:45.388Z
- SHA-256 of the archived text
0d983bf6eb67dc01263553b1cdfce0d28156148861f9485532183f0c9a94570f- Stable URL of this page
https://metraipolis.com/documento/dc_7ae93d60ceab
How to cite
Glucocorticoid reduction after starting crinecerfont in pediatric patients with classic congenital adrenal hyperplasia: practical perspectives — Europe PMC PMID:42082437 — Europe PMC (en), https://europepmc.org/article/MED/42082437 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ae93d60ceab (Metraipolis archive dc_7ae93d60ceab, sha256 0d983bf6eb67dc01263553b1cdfce0d28156148861f9485532183f0c9a94570f)
BibTeX
@misc{dc7ae93d60ceab,
title = {Glucocorticoid reduction after starting crinecerfont in pediatric patients with classic congenital adrenal hyperplasia: practical perspectives — Europe PMC PMID:42082437},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42082437},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ae93d60ceab; sha256 0d983bf6eb67dc01263553b1cdfce0d28156148861f9485532183f0c9a94570f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42082437. Agents can read the archived copy with the MCP tool read_document.